INDOMETHACIN & SARS-COV-2: PROSPECTS FOR CLINICAL MANAGEMENT OF THE INFLAMMATORY STATE. Review
Actuality. Severe acute respiratory syndrome- (SARS) is a pandemic (called as SARS-CoV-2 or COVID-19), severely affected by transmission and fatal disease caused by unknown coronavirus family of RNA virus (SARS-COV). The phenotype can range from asymptomatic to fulminate cytokine storm which leads t...
Main Authors: | S.R. Kodidala, J. Sorout, S. Jayachandra, V. Narapogu |
---|---|
Format: | Article |
Language: | English |
Published: |
Bogomolets National Medical University
2020-06-01
|
Series: | Медична наука України |
Subjects: | |
Online Access: | https://msu-journal.com/index.php/journal/article/view/217 |
Similar Items
-
Indomethacin & SARS-CoV-2: Prospects for clinical management of the inflammatory state
by: Satyanath R. Kodidala, et al.
Published: (2021-12-01) -
Physiological and clinical aspects in COVID-19
by: R. Kodidala Satyanath, et al.
Published: (2020-12-01) -
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2
by: Pantea Kiani, et al.
Published: (2021-03-01) -
Potentiation of Indomethacin-Induced Anti-Inflammatory Response by Montelukast in Formalin-Induced Inflammation in Rats
by: Ali Asghar Hemmati, et al.
Published: (2013-10-01) -
Psychosis secondary to indomethacin. A case report
by: S. Santiago González, et al.
Published: (2021-04-01)